insights_auto
Why is CSBR down 4,21%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
4,40 US$
arrow_downward
-4,21%(-0,19) 1D
19 ნოე, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,47 US$
High
4,47 US$
Low
4,40 US$
Mkt. cap
61,24 მლნ.
Avg. vol.
6,90 ათ.
Volume
0,00
52-wk high
8,31 US$
52-wk low
4,40 US$
EPS
-0,08 US$
Beta
0,47
Shares outstanding
13,92 მლნ.
No. of employees
217
Open
4,47 US$
High
4,47 US$
Low
4,40 US$
Mkt. cap
61,24 მლნ.
Avg. vol.
6,90 ათ.
Volume
0,00
52-wk high
8,31 US$
52-wk low
4,40 US$
EPS
-0,08 US$
Beta
0,47
Shares outstanding
13,92 მლნ.
No. of employees
217
News stories
From web sources and news partners
marketscreener.com
·
1 საათის წინ
Societe Generale sees S&P 500 ending 2027 at 8,500 on AI, earnings support
Traders Union
·
35 წუთის წინ
Mohamed A. El-Erian: S&P 500 may face longest losing streak since 2020 as 10-year Treasury yield falls
24/7 Wall St.
·
35 წუთის წინ
The S&P 500 Just Had Its Biggest Reversal Since March 2020
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ნიუ-ჯერსი, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitechampionsoncology.com